Results 31 to 40 of about 5,003 (295)
Platelet transfusions in hematological disorders [PDF]
Platelets are important for clot formation and vascular integrity. Thrombocytopenic patients with hematological disorders are at risk of bleeding and platelet transfusions are important in supportive care and treatment of lite-threatening bleedings ...
Karlström, Cecilia
core +1 more source
Leucoreduction of blood components. an effective way to increase blood safety? [PDF]
Over the past 30 years, it has been demonstrated that removal of white blood cells from blood components is effective in preventing some adverse reactions such as febrile non-haemolytic transfusion reactions, immunisation against human leucocyte antigens
Bianchi, Maria+6 more
core +1 more source
Factors influencing transfusion-associated HLA sensitization in patients bridged to heart transplantation using ventricular assist device. [PDF]
BackgroundBridging heart failure patients with mechanical ventricular assist devices (VAD) enables access to transplantation. However, VAD is associated with increased risk for anti-HLA antibodies associated with rejection of subsequent allografts ...
Adler, Eric+5 more
core +1 more source
Intraoperative blood transfusions in highly alloimmunized patients undergoing orthotopic liver transplantation. [PDF]
Intraoperative blood requirements were analyzed in patients undergoing primary orthotopic liver transplantation and divided into two groups on the basis of panel reactive antibody of pretransplant serum measured by lymphocytotoxicity testing.
Duquesnoy, RJ+5 more
core +1 more source
Refraktori Trombosit pada Ibu dengan Trombositopenia dalam Kehamilan [PDF]
Pendahuluan: Refraktori trombosit selalu menjadi masalah pada pasien trombositopenia karena meningkatkan risiko perdarahan spontan yang dapat mengancam jiwa. Kondisi ini menjadi penyulit dalam terapi pasien trombositopenia dan perdarahan. Penyebab paling
Hikmah, Nurul, Subono, Riska
core +1 more source
Background At our institution, patients with platelet refractoriness (of any etiology) are sometimes switched from apheresis platelets to pooled platelets before human leukocyte antigen (HLA)-matched units become available. Study design and methods Seven
Ying-Hsia Chu+3 more
doaj +1 more source
Background: Platelet refractoriness complicates the provision of platelet transfusions- a critical and essential part in management of thrombocytopenia in Oncology patients. Platelet refractoriness poses challenge due to alloimmunization to HLA (Class I)
Sadhana Mangwana+2 more
doaj +1 more source
Transfusion effect of 0.5-dose of apheresis platelet in pediatric patients
Objective To investigate the transfusion effect of 0.5-dose of apheresis platelet in pediatric patients. Methods A total of 195 children who underwent 0.5-dose platelet transfusion from August 2021 to June 2022 were enrolled, and the platelet count ...
Lijuan QIU+3 more
doaj +1 more source
Platelet transfusion support is extensively required for hemato-oncology patients who are multiply transfused. Platelet refractoriness can represent a significant clinical condition that complicates the platelet transfusion support in such patients.
B Sunil Rajadhyaksha+2 more
doaj +1 more source
Background and Aims Platelet transfusion refractoriness is well aware to be associated with poor clinical outcomes. Patients with the alloantibody causing refractoriness required cross‐matched compatible products to improve the platelet number.
Thunnakhon Sinwatcharaphirom+2 more
doaj +1 more source